June 23, 2026, 4:07 p.m. ET A Florida man with stage 4 pancreatic cancer is fighting to receive a new, promising drug. The FDA has approved the drug, Daraxonrasib, for an Expanded Access Program for patients outside of clinical trials. The drug's manufacturer and its distributor have delayed its release, citing distribution issues. The patient's fight has gained support from Mark Cuban, Congressman Brian Mast, and the FDA.